These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

160 related articles for article (PubMed ID: 45837)

  • 41. Immunosuppressive activity of serum during the development of experimental allergic encephalomyelitis.
    Vandenbark AA; Gibbins BL; Hinrichs DJ
    Cell Immunol; 1974 Mar; 11(1-3):1-10. PubMed ID: 4141934
    [No Abstract]   [Full Text] [Related]  

  • 42. Heat shock proteins and experimental autoimmune encephalomyelitis (EAE): I. Immunization with a peptide of the myelin protein 2',3' cyclic nucleotide 3' phosphodiesterase that is cross-reactive with a heat shock protein alters the course of EAE.
    Birnbaum G; Kotilinek L; Schlievert P; Clark HB; Trotter J; Horvath E; Gao E; Cox M; Braun PE
    J Neurosci Res; 1996 May; 44(4):381-96. PubMed ID: 8739158
    [TBL] [Abstract][Full Text] [Related]  

  • 43. High dose inhibition of the tryptophan peptide induced encephalitogenicity.
    Westall FC
    Immunol Commun; 1978; 7(1):57-67. PubMed ID: 75835
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Myelin basic protein: structure, function and antigenic determinants.
    Hashim GA
    Immunol Rev; 1978; 39():60-107. PubMed ID: 75170
    [No Abstract]   [Full Text] [Related]  

  • 45. Experimental allergic encephalomyelitis: species variability of the encephalitogenic determinant.
    Swanborg RH; Amesse LS
    J Immunol; 1971 Jul; 107(1):281-3. PubMed ID: 4103918
    [No Abstract]   [Full Text] [Related]  

  • 46. Experimental allergic encephalomyelitis in the rat: response to encephalitogenic proteins and peptides.
    McFarlin DE; Blank SE; Kibler RF; McKneally S; Shapira R
    Science; 1973 Feb; 179(4072):478-80. PubMed ID: 4122324
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Immune responses to myelin basic protein in mycobacterial-induced suppression of experimental allergic encephalomyelitis.
    Lisak RP; Zweiman B
    Cell Immunol; 1974 Nov; 14(2):242-54. PubMed ID: 4143110
    [No Abstract]   [Full Text] [Related]  

  • 48. Encephalitogenic properties of myelin from the quaking mutant.
    Brostoff SE; Powers JM; Wisniewski HM; Hogan EL
    Brain Res; 1976 May; 107(3):633-7. PubMed ID: 57821
    [No Abstract]   [Full Text] [Related]  

  • 49. [Electrophoretic mobility of lymph node cells in experimental allergic encephalomyelitis].
    Jenssen HL; Köhler H; Gundlach HJ; Günther J; Eckert R
    Acta Biol Med Ger; 1974; 32(1):113-9. PubMed ID: 4547024
    [No Abstract]   [Full Text] [Related]  

  • 50. The location of regions in guinea pig and bovine myelin basic proteins which induce experimental allergic encephalomyelitis in Lewis rats.
    Martenson RE; Levine S; Sowindki R
    J Immunol; 1975 Feb; 114(2 Pt 1):592-6. PubMed ID: 47354
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Antigen-dependent alterations in the lipid composition of the CNS in guinea pigs with experimental allergic encephalomyelitis.
    Maggio B; Cumar FA
    Brain Res; 1974 Sep; 77(2):297-307. PubMed ID: 4136536
    [No Abstract]   [Full Text] [Related]  

  • 52. Antigenic determinants on bovine encephalitogenic protein: studies in rabbits with derivatives of fragment 1-43 and the lymph node cell transformation test.
    Bergstrand H; Källén B
    Neurobiology; 1973; 3(4):246-55. PubMed ID: 4127145
    [No Abstract]   [Full Text] [Related]  

  • 53. [The role of cellular factors in the pathogenesis of experimental allergic encephalomyelitis].
    Kantchourine AK; Posina IM
    Rev Immunol Ther Antimicrob; 1969; 33(3):111-8. PubMed ID: 5799851
    [No Abstract]   [Full Text] [Related]  

  • 54. Immunologic properties of the main encephalitogenic peptide from the basic protein of human myelin.
    Lennon VA; Wilks AV; Carnegie PR
    J Immunol; 1970 Nov; 105(5):1223-30. PubMed ID: 4099924
    [No Abstract]   [Full Text] [Related]  

  • 55. The lysosomal enzymic activities of lymphocytes in experimental allergic encephalomyelitis.
    Clausen J; Jorgensen P
    Int Arch Allergy Appl Immunol; 1972; 43(3):457-68. PubMed ID: 4117489
    [No Abstract]   [Full Text] [Related]  

  • 56. [Macrophage migration inhibition test (M.I.T) in experimental allergic encephalitis].
    Del rey Calero J; Calbo Torrecillas F; Otero Puime AA; Gonzalez R-Salinas MC
    Rev Sanid Hig Publica (Madr); 1970 Dec; 44(12):1307-18. PubMed ID: 5525220
    [No Abstract]   [Full Text] [Related]  

  • 57. Studies on lymphocyte transformation in experimental allergic encephalomyelitis.
    Warnatz H; Scheiffarth F; Kuntz H
    J Neuropathol Exp Neurol; 1970 Oct; 29(4):575-82. PubMed ID: 5471922
    [No Abstract]   [Full Text] [Related]  

  • 58. Adoptive transfer of experimental allergic encephalomyelitis: incubation of rat spleen cells with specific antigen.
    Richert JR; Driscoll BF; Kies MW; Alvord EC
    J Immunol; 1979 Feb; 122(2):494-6. PubMed ID: 84024
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Peptide length requirement for experimental allergic encephalomyelitis in guinea pigs.
    Levit S; Powers JM; Milek D; Brostoff SW
    Neurochem Res; 1980 Jan; 5(1):37-42. PubMed ID: 6154250
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Suppression of chronic allergic encephalomyelitis: relevance to multiple sclerosis.
    Raine CS; Traugott U; Stone SH
    Science; 1978 Aug; 201(4354):445-8. PubMed ID: 78524
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.